Indication
Thromboembolic disorder
A thromboembolic disorder is a vascular condition characterized by the formation of an intravascular blood clot that dislodges and travels downstream to occlude a distant blood vessel. Read more about Thromboembolic disorder
23 drugs 22 manufacturers
Drugs that treat it
Common Thromboembolic disorder therapies.
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA thromboembolic disorder is a vascular condition characterized by the formation of an intravascular blood clot that dislodges and travels downstream to occlude a distant blood vessel.
It affects both the venous and arterial circulations across diverse patient populations, particularly individuals with hypercoagulable states, prolonged immobility, malignancy, recent surgery, or underlying cardiovascular disease.
Pathophysiologically driven by endothelial injury, stasis of blood flow, and abnormal coagulation pathways, the condition can manifest as venous thromboembolism—including deep vein thrombosis and pulmonary embolism—or as arterial occlusion leading to end-organ ischemia and infarction.
- nih.gov
A thromboembolic disorder is a vascular condition characterized by the formation of an intravascular blood clot that dislodges and travels downstream to occlude a distant blood vessel
- medlineplus.gov
A thromboembolic disorder is a vascular condition characterized by the formation of an intravascular blood clot that dislodges and travels downstream to occlude a distant blood vessel It affects both the venous and arterial circulations across diverse patient populations, particularly individuals with hypercoagulable states, prolonged immobility, malignancy, recent surgery, or underlying cardiovascular disease Pathophysiologically driven by endothelial injury, stasis of blood flow, and abnormal ...
- nih.gov
It affects both the venous and arterial circulations across diverse patient populations, particularly individuals with hypercoagulable states, prolonged immobility, malignancy, recent surgery, or underlying cardiovascular disease Pathophysiologically driven by endothelial injury, stasis of blood flow, and abnormal coagulation pathways, the condition can manifest as venous thromboembolism—including deep vein thrombosis and pulmonary embolism—or as arterial occlusion leading to end-organ ischemia ...
- nih.gov
It affects both the venous and arterial circulations across diverse patient populations, particularly individuals with hypercoagulable states, prolonged immobility, malignancy, recent surgery, or underlying cardiovascular disease
- nih.gov
Pathophysiologically driven by endothelial injury, stasis of blood flow, and abnormal coagulation pathways, the condition can manifest as venous thromboembolism—including deep vein thrombosis and pulmonary embolism—or as arterial occlusion leading to end-organ ischemia and infarction
Personalize your experience
Follow Thromboembolic disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.